|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1R01AG057598-01 |
Development of Attenuated Furoxans as Novel Therapies for Alzheimers Disease |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIA |
$250,000 |
$133,750 |
$383,750 |
| 1R01HL143082-01 |
Genetic, Epigenetic and Dietary Salt effects on Microbiota and Hypertension |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NHLBI |
$421,911 |
$225,722 |
$647,633 |
| 1R03DA045350-01A1 |
High throughput approaches to determining the lethality of synthetic psychoactive cathinones using Danio rerio larvae |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIDA |
$50,000 |
$26,750 |
$76,750 |
| 1R03DA045833-01 |
In Vivo Photoaffinity Labeling using Casper Zebrafish for Target Identification |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIDA |
$50,000 |
$26,750 |
$76,750 |
| 1R15GM131329-01 |
Identification of the Elusive NAADP Receptor |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIGMS |
$325,920 |
$135,978 |
$461,898 |
| 1R15HL140523-01 |
Primary cilia dysfunction and cardiovascular complications in Polycystic Kidney Disease |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NHLBI |
$277,349 |
$101,635 |
$378,984 |
| 1R21AA026017-01A1 |
How Non-transcriptional IRF3 Prevents ALD |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIAAA |
$143,750 |
$76,906 |
$220,656 |
| 3OT2OD023859-01S2 |
Anatomical-Functional Mapping of Enteric Neural Circuits |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
OD |
$2,385,639 |
$605,036 |
$2,836,600 |
| 5K01HL125445-04 |
Antioxidant-PPARalpha interaction and hypertension |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NHLBI |
$151,123 |
$12,090 |
$163,213 |
| 5P40OD021331-05 |
Resource for Rat Genetic Models of Aerobic Capacity |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
OD |
$177,812 |
$95,129 |
$272,941 |
| 5R01AI121970-03 |
Intravital assessment of Borrelia burgdorferi immune clearance in skin |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIAID |
$260,154 |
$116,654 |
$376,808 |
| 5R01CA219144-03 |
Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NCI |
$203,869 |
$85,475 |
$289,344 |
| 5R01DK114006-03 |
The Melanocortinergic pathway inglomerular disease |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIDDK |
$227,790 |
$121,868 |
$349,658 |
| 5R01HD081792-04 |
Defective melanocortin signaling underlying T2D-associated erectile dysfunction |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NICHD |
$224,912 |
$98,603 |
$323,515 |
| 5R01HL112937-05 |
Role of complement regulator properdin in the interaction between platelets and l |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NHLBI |
$250,000 |
$128,750 |
$378,750 |
| 5R01HL137004-02 |
Counter regulatory mechanisms of cardiotonic steroids in cardio-renal syndrome |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NHLBI |
$250,000 |
$128,750 |
$378,750 |
| 5R01MH110483-03 |
Study of early brain alterations that predict development of chronic PTSD |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NIMH |
$485,988 |
$189,642 |
$675,630 |
| 5R03CA198696-02 |
Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NCI |
$50,000 |
$26,750 |
$76,750 |
| 5R03CA216153-02 |
Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma |
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS |
NCI |
$50,000 |
$26,750 |
$76,750 |